Categories: High-Tech

Israeli startup’s innovative prostate device receives European CE approval

The Israeli medical device startup Butterfly Medical announced last week that its innovative medical device for non-surgical, office-based treatment of Benign Prostate Hyperplasia (BPH) has received European CE approval. This innovative device provides a simple, fast and minimally invasive, in-office procedure to BPH patients.









Photo Credit: Butterfly Medical

Last week, the Israeli medical device startup Butterfly Medical, an Alon Medtech company, announced that its innovative medical device for non-surgical, office-based treatment of Benign Prostate Hyperplasia (BPH) has received European CE approval.

BPH affects about 105 million men globally, the majority of whom are over the age of 50. According to Prostate Cancer UK, four out of every 10 men over the age of 50 have an enlarged prostate that causes them severe urinary problems.

Medication is usually the first type of therapy doctors prescribe. However, the relief can be inadequate and temporary and thus patients often end up needing invasive surgery. Butterfly Medical’s device expands the treatment options for BPH patients.

The novel device provides a simple, fast and minimally invasive, in-office procedure to BPH patients who are suffering. Butterfly Medical’s device enables doctors to treat their patients in less than 10 minutes from the comfort of their office under local anesthesia. The device provides instant relief, enabling the patients to go back to their normal activities immediately.

“We are proud to bring a simple, non-surgical treatment option to the millions of men worldwide afflicted by BPH. With our Butterfly Medical device, they are able to receive treatment quickly and easily in their physician’s office,” said Idan Geva, CEO Butterfly Medical. “With market acceptance for our medical approach already demonstrated, our closest competitor was sold for over $1 billion, our European market approval puts us right on the map.”

Chairman of Butterfly Medical and Active Chairman of Alon Medtech, Dr. Shimon Eckhouse said: “Butterfly is a great example of our approach at Alon Medtech of building successful companies with our entrepreneurs to bring innovative products to large, high growth markets. The CE approval of the Butterfly device is a very important milestone in the life of the company enabling it to access the European market in the very near future.”

Becca Noy

Share
Published by
Becca Noy

Recent Posts

‘The State of Palestine’ Never Heard of It

The State of Palestine remains unrecognized by numerous UN members and holds non-member observer status at the organization since November…

8 hours ago

Only the Tip of The Iceberg

Prior to the Islamic Revolution that swept Iran in 1979, the status of Shiite Muslims in the Arab world (about…

8 hours ago

Strange Academic Paper Calls Palestinian Women ”Martyrs”

This very strange academic paper seems more interested in the science of death, rather than haphazardly calling the Palestinian women…

8 hours ago

Op-Ed: Stop the Slander Against Human Rights Advocates Now

Socrates once said, “When the debate is lost, slander becomes the tool of the loser.” If one is following the…

8 hours ago

All About Roseanne

30 Years ago today “Roseanne“ premiered on October 18, 1988 on ABC. The series followed the ordinary working-class family of…

1 day ago

Hide and Seek

The Hamas leadership moved into underground hideouts overnight to avoid further Israeli attacks against positions of the Islamic terrorist organization,…

1 day ago